154 related articles for article (PubMed ID: 33827312)
1. Recurrent Thrombi in an Obese Patient With History of Bariatric Surgery Despite Anti-Xa Therapy.
Briggler R; Matherne E; Johnson C; Boehmer K
J Pharm Pract; 2022 Oct; 35(5):811-816. PubMed ID: 33827312
[TBL] [Abstract][Full Text] [Related]
2. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center: A pilot study.
Signorelli JR; Gandhi AS
J Oncol Pharm Pract; 2019 Mar; 25(2):362-368. PubMed ID: 29157146
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
[TBL] [Abstract][Full Text] [Related]
5. CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS -
Mechanick JI; Apovian C; Brethauer S; Garvey WT; Joffe AM; Kim J; Kushner RF; Lindquist R; Pessah-Pollack R; Seger J; Urman RD; Adams S; Cleek JB; Correa R; Figaro MK; Flanders K; Grams J; Hurley DL; Kothari S; Seger MV; Still CD
Endocr Pract; 2019 Dec; 25(12):1346-1359. PubMed ID: 31682518
[No Abstract] [Full Text] [Related]
6. Bariatric venous thromboembolism prophylaxis: an update on the literature.
Hamadi R; Marlow CF; Nassereddine S; Taher A; Finianos A
Expert Rev Hematol; 2019 Sep; 12(9):763-771. PubMed ID: 31219356
[No Abstract] [Full Text] [Related]
7. Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.
Gao JH; Chu XC; Wang LL; Ning B; Zhao CX
Medicine (Baltimore); 2017 Oct; 96(40):e8059. PubMed ID: 28984761
[TBL] [Abstract][Full Text] [Related]
8. Current management of acute symptomatic deep vein thrombosis.
Heit JA
Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Body Mass Index-Based Prophylactic Enoxaparin Dosing in Bariatric Surgery Patients.
Chang CK; Higgins RM; Rein L; Peppard WJ; Herrmann DJ; Kindel T
J Surg Res; 2023 Jul; 287():168-175. PubMed ID: 36933548
[TBL] [Abstract][Full Text] [Related]
10. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R
PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116
[TBL] [Abstract][Full Text] [Related]
11. Oral Anticoagulant Use in Morbid Obesity and Post Bariatric Surgery: A Review.
Nasser MF; Jabri A; Gandhi S; Rader F
Am J Med; 2021 Dec; 134(12):1465-1475. PubMed ID: 34403701
[TBL] [Abstract][Full Text] [Related]
12. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
[TBL] [Abstract][Full Text] [Related]
13. Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients.
Karas LA; Nor Hanipah Z; Cetin D; Schauer PR; Brethauer SA; Daigle CR; Aminian A
Surg Obes Relat Dis; 2021 Jan; 17(1):153-160. PubMed ID: 33046419
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place.
Ha NB; Regal RE
Ann Pharmacother; 2016 May; 50(5):402-9. PubMed ID: 26861989
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
Perales IJ; San Agustin K; DeAngelo J; Campbell AM
Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
[No Abstract] [Full Text] [Related]
17. Outpatient management of anticoagulation therapy.
du Breuil AL; Umland EM
Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary Embolism Despite Rivaroxaban in an Obese Patient].
Schuh T; Stöllberger C
Dtsch Med Wochenschr; 2017 Oct; 142(20):1548-1551. PubMed ID: 29017215
[TBL] [Abstract][Full Text] [Related]
19. Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric Surgery.
Kok T; de Boer H; Witteman B; Hovens M; van Luin M; Monajemi H
Obes Surg; 2022 Mar; 32(3):607-614. PubMed ID: 34822108
[TBL] [Abstract][Full Text] [Related]
20. Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy.
Wilbur J; Shian B
Am Fam Physician; 2017 Mar; 95(5):295-302. PubMed ID: 28290648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
